Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma

Haematologica. 2015 Nov;100(11):e467-70. doi: 10.3324/haematol.2015.126854. Epub 2015 Jul 23.
No abstract available

Keywords: BLIMP1/PRDM1; PEL; RNAi; liposomes; siRNA.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Female
  • Humans
  • Liposomes
  • Lymphoma, Primary Effusion / drug therapy*
  • Lymphoma, Primary Effusion / genetics
  • Lymphoma, Primary Effusion / metabolism
  • Male
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Positive Regulatory Domain I-Binding Factor 1
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology*
  • Repressor Proteins / antagonists & inhibitors*
  • Repressor Proteins / biosynthesis

Substances

  • Antineoplastic Agents
  • Liposomes
  • Neoplasm Proteins
  • RNA, Small Interfering
  • Repressor Proteins
  • PRDM1 protein, human
  • Positive Regulatory Domain I-Binding Factor 1